Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
Imaizumi S, Shiga Y, Ogawa M, Sako H, Nagata Y, Matsunaga A, Shirotani T, Hoshino F, Yahiro E, Uehara Y, Morito N, Tanigawa H, Shimono D, Fukushima M, Sugihara H, Norimatsu K, Kusumoto T, Saku K, Miura SI; ACADEMIE Study Investigators. Imaizumi S, et al. Among authors: yahiro e. Heart Vessels. 2020 Apr;35(4):603-604. doi: 10.1007/s00380-019-01374-5. Heart Vessels. 2020. PMID: 30972549
Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
Imaizumi S, Shiga Y, Ogawa M, Sako H, Nagata Y, Matsunaga A, Shirotani T, Hoshino F, Yahiro E, Uehara Y, Morito N, Tanigawa H, Shimono D, Fukushima M, Sugihara H, Norimatsu K, Kusumoto T, Saku K, Miura SI; ACADEMIE Study Investigators. Imaizumi S, et al. Among authors: yahiro e. Heart Vessels. 2019 Apr;34(4):698-710. doi: 10.1007/s00380-018-1286-2. Epub 2018 Nov 8. Heart Vessels. 2019. PMID: 30406819 Clinical Trial.
Visit-to-Visit Variability and Seasonal Variation in Blood Pressure With Single-Pill Fixed-Dose Combinations of Angiotensin II Receptor Blocker/Calcium Channel Blocker and Angiotensin II Receptor Blocker/Diuretic in Hypertensive Patients.
Shiga Y, Miura S, Adachi S, Suematsu Y, Sugihara M, Iwata A, Yahiro E, Nishikawa H, Ogawa M, Saku K. Shiga Y, et al. Among authors: yahiro e. J Clin Med Res. 2015 Oct;7(10):802-6. doi: 10.14740/jocmr2292w. Epub 2015 Aug 23. J Clin Med Res. 2015. PMID: 26346540 Free PMC article.
Effects of Tolvaptan With or Without the Pre-Administration of Renin-Angiotensin System Blockers in Hospitalized Patients With Acute Decompensated Heart Failure.
Adachi S, Miura SI, Shiga Y, Arimura T, Morii J, Kuwano T, Kitajima K, Iwata A, Morito N, Fujimi K, Yahiro E, Nishikawa H, Saku K. Adachi S, et al. Among authors: yahiro e. Int Heart J. 2017 May 31;58(3):385-392. doi: 10.1536/ihj.16-220. Epub 2017 May 8. Int Heart J. 2017. PMID: 28484118 Free article.
LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice.
Suematsu Y, Miura S, Goto M, Matsuo Y, Arimura T, Kuwano T, Imaizumi S, Iwata A, Yahiro E, Saku K. Suematsu Y, et al. Among authors: yahiro e. Eur J Heart Fail. 2016 Apr;18(4):386-93. doi: 10.1002/ejhf.474. Epub 2016 Jan 7. Eur J Heart Fail. 2016. PMID: 26749570 Free article.
42 results